Eli Lilly and Company (LLY)
NYSE · Healthcare
Eli Lilly and Company Income Statement 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | 65.18B | 45.04B | 34.12B | 28.54B | 28.32B | 24.54B |
| Gross Profit | 54.13B | 36.62B | 27.04B | 21.91B | 21.01B | 19.06B |
| Profitability | ||||||
| Operating Income | 29.70B | 17.04B | 10.79B | 8.65B | 7.93B | 7.10B |
| EBITDA | 35.09B | 19.42B | 12.46B | 10.22B | 9.56B | 8.26B |
| Net Income | 20.64B | 10.59B | 5.24B | 6.24B | 5.58B | 6.19B |
| Per Share Data | ||||||
| EPS (diluted) | $22.95 | $11.71 | $5.80 | $6.57 | $5.85 | $6.47 |
| Shares Outstanding (dil.) | 895M | 898M | 899M | 950M | 954M | 957M |
Eli Lilly and Company Income Statement — FAQ
Eli Lilly and Company (LLY) income statement over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LLY's income statement history?
The chart and table above show Eli Lilly and Company's income statement by year and by quarter, including the growth rate.